I'm an oncologist treating patients with leukemia and other blood cancers. My specific areas of focus include adult T cell leukemia-lymphoma, bone marrow transplantation and chronic b-cell lymphocytic leukemia. I serve as Professor of Internal Medicine and Member of Molecular Biology/Cancer Genetics Program at the OSUCCC – James.
Research is an important part of my career. I'm a lead researcher in an OSUCCC – James program that examines the role of RNA molecules in the development of leukemia, and I've participated in numerous clinical trials in an effort to discover more effective leukemia therapies. I'm grateful for the opportunity to collaborate with world-class colleagues in the search for a cure.
My work has been published in several medical journals including British Journal of Cancer, Clinical Cancer Research and Molecular Cell Biology. I was an invited abstract reviewer and oral session moderator at the American Society of Hematology Annual meeting in 2013. More than 25 national and international organizations have invited me to review grant proposals.
I stay current with developments in my field as a member of several national and international professional societies. I'm an active participant in the American Society of Hematology, American Society of Clinical Oncology and the European Hematology Association. I'm excited to continue my career at the OSUCCC – James, where we continue to discover new therapies that lead to improved patient outcomes and our shared goal of a world free of cancer.
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 12/20/2018, Dr. Garzon has reported no relationships with companies or entities.